UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023649
Receipt number R000027237
Scientific Title Luseogliflozin Ehime Diabetes Study (LED study)
Date of disclosure of the study information 2016/08/17
Last modified on 2019/02/12 15:09:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Luseogliflozin Ehime Diabetes Study (LED study)

Acronym

LED Study

Scientific Title

Luseogliflozin Ehime Diabetes Study (LED study)

Scientific Title:Acronym

LED Study

Region

Japan


Condition

Condition

Type 2 Diabetes Mellitus

Classification by specialty

Hepato-biliary-pancreatic medicine Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the changes of energy intake, eating behavior, HbA1c and Weight after administration of luseogliflozin.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase IV


Assessment

Primary outcomes

The change of HbA1c, fasting glucose level, energy intake, and eating behavior.

The association between energy intake and HbA1c.

Key secondary outcomes

Weight, Abdominal circumference,
Lipid profile, liver function test, renal function, heart function, and organ damage marker.

The severity of nocturia and sleep time.

The frequency of hypoglycemia.

The change of intestinal bacterial flora.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Luseogliflozin 214 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Body mass Index more than 23

More than estimated GFR 30

Written informed consent was obtained from all patients enrolled in the this Study

Key exclusion criteria

contraindication of Luseogliflozin, type 1 diabetes mellitus, cancer, history of severe hypoglycemia, ketoacidosis, skin disease during treatment, repeated genital infection and urinary tract infection
Sleep disorder related to the otolaryngology disease, neurological disease, hypothyroidism and acromegaly.
Severe hepatic insufficiency defined as aspartate aminotransferase (AST) >3x upper limit of normal (ULN) and/or alanine aminotransferase (ALT) >3x ULN.
Total bilirubin >2.0 mg/dL .
Positive serologic evidence of current infectious liver disease including Hepatitis B viral antibody IgG, Hepatitis B viral antibody IgM, Hepatitis B surface antigen and Hepatitis C virus antibody.
History of unstable or rapidly progressing renal disease.
Volume depleted patients.
Recent Cardiovascular Events in a patient: Acute Coronary Syndrome (ACS) within 2 months prior to enrolment, Hospitalization for unstable angina or acute myocardial infarction within 2 months prior to enrolment, Acute Stroke or TIA within two months prior to enrolment, and Less than two months post coronary artery revascularization
Pregnant or breastfeeding patients.
Congestive heart failure defined as New York Heart Association (NYHA) class IV, unstable or acute congestive heart failure.
Patients using other SGLT2 inhibitor.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinya Furukawa

Organization

Ehime University Graduate School of Medicine

Division name

Department of Epidemiology and Preventive Medicine

Zip code


Address

Shitsukawa, Toon, Ehime, Japan

TEL

0899605283

Email

shinfuru@m.ehime-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shinya Furukawa

Organization

Ehime University Graduate School of Medicine

Division name

Department of Epidemiology and Preventive Medicine

Zip code


Address

Shitsukawa, Toon, Ehime, Japan

TEL

0899605283

Homepage URL


Email

shinfuru@m.ehime-u.ac.jp


Sponsor or person

Institute

Department of Epidemiology and Preventive Medicine, Ehime University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Taisho Toyama Phama

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 05 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 05 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 08 Month 17 Day

Last modified on

2019 Year 02 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027237


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name